5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine

C108H117F2N15O8 — CID 159122504

IUPAC5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine
SMILESCC1(Oc2ccc3c(c2)C(c2ccnc(N4CCOCC4)c2)=NC3)CC1.C[C@@H]1CN(c2cc(C3=NCc4ccc(OC5(C)CC5)cc43)ccn2)CCO1.C[C@H]1CN(c2cc(C3=NCc4ccc(OC5(C)CC5)cc43)ccn2)CCO1.FC1(F)CN(c2cc(C3=NCc4ccc(OC5CC5)cc43)ccn2)C1.c1cc(C2=NCc3ccc(OC4CC4)cc32)cc(N2CCC(C3CC3)CC2)n1
InChIInChI=1S/C24H27N3O.2C22H25N3O2.C21H23N3O2.C19H17F2N3O/c1-2-16(1)17-8-11-27(12-9-17)23-13-18(7-10-25-23)24-22-14-21(28-20-5-6-20)4-3-19(22)15-26-24;2*1-15-14-25(9-10-26-15)20-11-16(5-8-23-20)21-19-12-18(27-22(2)6-7-22)4-3-17(19)13-24-21;1-21(5-6-21)26-17-3-2-16-14-23-20(18(16)13-17)15-4-7-22-19(12-15)24-8-10-25-11-9-24;20-19(21)10-24(11-19)17-7-12(5-6-22-17)18-16-8-15(25-14-3-4-14)2-1-13(16)9-23-18/h3-4,7,10,13-14,16-17,20H,1-2,5-6,8-9,11-12,15H2;2*3-5,8,11-12,15H,6-7,9-10,13-14H2,1-2H3;2-4,7,12-13H,5-6,8-11,14H2,1H3;1-2,5-8,14H,3-4,9-11H2/t;2*15-;;/m.10../s1
InChIKeyKFWHGKCMFIQHOF-FFCQYTTBSA-N
MW1791.22 g/mol
LogP18.41
Rot. Bonds21

About 5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine

5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine (PubChem CID 159122504) has the molecular formula C108H117F2N15O8 and a molecular weight of 1791.22 g/mol. Its IUPAC name is 5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine.

Molecular Properties

Compound Name5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine
PubChem CID159122504
Molecular FormulaC108H117F2N15O8
Molecular Weight1791.22 g/mol
Exact Mass1789.92
IUPAC Name5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine
SMILESCC1(Oc2ccc3c(c2)C(c2ccnc(N4CCOCC4)c2)=NC3)CC1.C[C@@H]1CN(c2cc(C3=NCc4ccc(OC5(C)CC5)cc43)ccn2)CCO1.C[C@H]1CN(c2cc(C3=NCc4ccc(OC5(C)CC5)cc43)ccn2)CCO1.FC1(F)CN(c2cc(C3=NCc4ccc(OC5CC5)cc43)ccn2)C1.c1cc(C2=NCc3ccc(OC4CC4)cc32)cc(N2CCC(C3CC3)CC2)n1
InChIInChI=1S/C24H27N3O.2C22H25N3O2.C21H23N3O2.C19H17F2N3O/c1-2-16(1)17-8-11-27(12-9-17)23-13-18(7-10-25-23)24-22-14-21(28-20-5-6-20)4-3-19(22)15-26-24;2*1-15-14-25(9-10-26-15)20-11-16(5-8-23-20)21-19-12-18(27-22(2)6-7-22)4-3-17(19)13-24-21;1-21(5-6-21)26-17-3-2-16-14-23-20(18(16)13-17)15-4-7-22-19(12-15)24-8-10-25-11-9-24;20-19(21)10-24(11-19)17-7-12(5-6-22-17)18-16-8-15(25-14-3-4-14)2-1-13(16)9-23-18/h3-4,7,10,13-14,16-17,20H,1-2,5-6,8-9,11-12,15H2;2*3-5,8,11-12,15H,6-7,9-10,13-14H2,1-2H3;2-4,7,12-13H,5-6,8-11,14H2,1H3;1-2,5-8,14H,3-4,9-11H2/t;2*15-;;/m.10../s1
InChIKeyKFWHGKCMFIQHOF-FFCQYTTBSA-N
XLogP18.41
TPSA216.29 Ų
H-Bond Donors
H-Bond Acceptors23
Rotatable Bonds21
Heavy Atoms133
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001791.22
LogP ≤ 518.41
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1023

Analyze 5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3-[6-(4-cyclopropylpiperazin-1-yl)pyrimidin-4-yl]-5-[(2S)-1-methoxypropan-2-yl]oxy-1H-isoindole;3-[6-(3,3-difluoroazetidin-1-yl)pyrimidin-4-yl]-5-[(2S)-1-methoxypropan-2-yl]oxy-1H-isoindole;3-[6-[(3S,4S)-3,4-difluoropyrrolidin-1-yl]pyrimidin-4-yl]-5-[(2S)-1-methoxypropan-2-yl]oxy-1H-isoindole;2-(methoxymethyl)-4-[6-[6-[(2S)-1-methoxypropan-2-yl]oxy-3H-isoindol-1-yl]pyrimidin-4-yl]morpholine;(3S,5R)-4-[6-[6-[(2S)-1-methoxypropan-2-yl]oxy-3H-isoindol-1-yl]pyrimidin-4-yl]-3,5-dimethylmorpholine;(3S)-4-[6-[6-[(2S)-1-methoxypropan-2-yl]oxy-3H-isoindol-1-yl]pyrimidin-4-yl]-3-methylmorpholine
CID 157507598
3-fluoro-N-[4-(6-propan-2-yloxy-3H-isoindol-1-yl)-2-pyridinyl]benzenesulfinamide;3-[2-(3-methoxy-3-methylazetidin-1-yl)-4-pyridinyl]-5-(trifluoromethoxy)-1H-isoindole;3-methoxy-N-[4-(6-propan-2-yloxy-3H-isoindol-1-yl)-2-pyridinyl]benzenesulfinamide;3-[2-(3-methylsulfonylazetidin-1-yl)-4-pyridinyl]-1H-isoindol-5-ol;3-(2-piperidin-1-yl-4-pyridinyl)-1H-isoindol-5-ol;dihydrate
CID 158152696
3-[2-(4-cyclopropylpiperazin-1-yl)-4-pyridinyl]-5-(trifluoromethoxy)-1H-isoindole;3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-5-(trifluoromethoxy)-1H-isoindole;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-(trifluoromethoxy)-1H-isoindole;3-[2-(3,3-difluoropyrrolidin-1-yl)-4-pyridinyl]-5-(trifluoromethoxy)-1H-isoindole;3-[2-(3-methoxyazetidin-1-yl)-4-pyridinyl]-5-(trifluoromethoxy)-1H-isoindole
CID 159116653
3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-ethoxy-1H-isoindole;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-isoindole;N-(2-methoxyethyl)-4-(6-propan-2-yloxy-3H-isoindol-1-yl)pyridin-2-amine;3-[2-(4-methoxypiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-isoindole;3-[2-(4-methylsulfonylpiperazin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-isoindole;4-[4-(6-propan-2-yloxy-3H-isoindol-1-yl)-2-pyridinyl]morpholine
CID 159400339
3-[2-(3,3-difluoropyrrolidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-isoindole;2,2,3,3,5,5,6,6-octadeuterio-4-[4-(6-propan-2-yloxy-3H-isoindol-1-yl)-2-pyridinyl]morpholine;1-[4-(6-propan-2-yloxy-3H-isoindol-1-yl)-2-pyridinyl]azetidine-3-carboxylic acid;3-[4-(6-propan-2-yloxy-3H-isoindol-1-yl)-2-pyridinyl]-8-oxa-3-azabicyclo[3.2.1]octane;8-[4-(6-propan-2-yloxy-3H-isoindol-1-yl)-2-pyridinyl]-3-oxa-8-azabicyclo[3.2.1]octane;6-[4-(6-propan-2-yloxy-3H-isoindol-1-yl)-2-pyridinyl]-2-oxa-6-azaspiro[3.3]heptane;1-[4-(6-propan-2-yloxy-3H-isoindol-1-yl)-2-pyridinyl]piperidin-4-ol
CID 160127188
3-[6-[(3R)-4-(1-cyclopropylpropan-2-yl)-3-methylpiperazin-1-yl]pyrimidin-4-yl]-5-(1-methylcyclopropyl)oxy-1H-isoindole;3-[6-[(3R)-4-(1,1-difluoropropan-2-yl)-3-methylpiperazin-1-yl]pyrimidin-4-yl]-5-(1-methylcyclopropyl)oxy-1H-isoindole;3-[6-[(3R)-4-ethyl-3-methylpiperazin-1-yl]pyrimidin-4-yl]-5-(1-methylcyclopropyl)oxy-1H-isoindole;3-[6-[(3R)-4-(1-methoxypropan-2-yl)-3-methylpiperazin-1-yl]pyrimidin-4-yl]-5-(1-methylcyclopropyl)oxy-1H-isoindole;5-(1-methylcyclopropyl)oxy-3-[6-[(3R)-3-methyl-4-(3,3,3-trifluoropropyl)piperazin-1-yl]pyrimidin-4-yl]-1H-isoindole
CID 160334125
5-cyclopropyloxy-3-[2-(3,3-difluoropiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoropyrrolidin-1-yl)-4-pyridinyl]-1H-isoindole;7-[4-(6-cyclopropyloxy-3H-isoindol-1-yl)-2-pyridinyl]-3-ethyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;(3S)-1-[4-(6-cyclopropyloxy-3H-isoindol-1-yl)-2-pyridinyl]pyrrolidin-3-ol;5-cyclopropyloxy-3-[2-[(3S)-3-methoxypyrrolidin-1-yl]-4-pyridinyl]-1H-isoindole
CID 161220829
3-[2-(8-azabicyclo[3.2.1]octan-8-yl)-4-pyridinyl]-5-ethoxy-1H-isoindole;3-[2-(azetidin-1-yl)-4-pyridinyl]-5-ethoxy-1H-isoindole;3-[4-(6-ethoxy-3H-isoindol-1-yl)-2-pyridinyl]-6-pyridin-2-yl-3-azabicyclo[3.1.0]hexane-6-carbonitrile;3-(2-piperidin-1-yl-4-pyridinyl)-5-(trifluoromethoxy)-1H-isoindole;1-[4-[6-(trifluoromethoxy)-3H-isoindol-1-yl]-2-pyridinyl]piperidin-4-ol
CID 161767533
3-[2-(3-methoxyazetidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-isoindole;3-[2-(3-methylsulfonylazetidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-isoindole;3-(2-piperidin-1-yl-4-pyridinyl)-5-propan-2-yloxy-1H-isoindole;4-[4-(6-propan-2-yloxy-3H-isoindol-1-yl)-2-pyridinyl]-3,5-dihydro-2H-1lambda6,4-benzothiazepine 1,1-dioxide;1-[4-(6-propan-2-yloxy-3H-isoindol-1-yl)-2-pyridinyl]-3-(trifluoromethyl)azetidin-3-ol
CID 161955646
3-[6-(4-cyclopropylpiperazin-1-yl)pyrimidin-4-yl]-5-propan-2-yloxy-1H-isoindole;3-[6-(4,7-diazaspiro[2.5]octan-7-yl)pyrimidin-4-yl]-5-propan-2-yloxy-1H-isoindole;3-[6-[4-(2-fluoroethyl)piperazin-1-yl]pyrimidin-4-yl]-5-propan-2-yloxy-1H-isoindole;3-methyl-4-[6-(6-propan-2-yloxy-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;2,2,3,3,5,5,6,6-octadeuterio-4-[6-(6-propan-2-yloxy-3H-isoindol-1-yl)pyrimidin-4-yl]morpholine;5-propan-2-yloxy-3-[6-(4-propylpiperazin-1-yl)pyrimidin-4-yl]-1H-isoindole
CID 157245089
dicesium;fluorochloranuidylmethane;bis(4-[4-[6-(fluoromethoxy)-3H-isoindol-1-yl]-2-pyridinyl]morpholine);hydride;methane;3-(2-morpholin-4-yl-4-pyridinyl)-1H-isoindol-5-ol;oxido formate
CID 157295848
(2R,6S)-4-[6-[5-fluoro-6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]pyrimidin-4-yl]-2,6-dimethylmorpholine;(2S)-4-[6-[5-fluoro-6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]pyrimidin-4-yl]-2-methylmorpholine;(2R)-4-[6-[5-fluoro-6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]pyrimidin-4-yl]-2-methylmorpholine;4-[6-[5-fluoro-6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]pyrimidin-4-yl]morpholine;6-fluoro-5-(1-methylcyclopropyl)oxy-3-[6-(4-methylpiperazin-1-yl)pyrimidin-4-yl]-1H-isoindole
CID 157413623

Frequently Asked Questions

What is the IUPAC name of 5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine?
The IUPAC name of 5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine (CID 159122504) is 5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine.
What is the SMILES notation for 5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine?
The canonical SMILES for 5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine is CC1(Oc2ccc3c(c2)C(c2ccnc(N4CCOCC4)c2)=NC3)CC1.C[C@@H]1CN(c2cc(C3=NCc4ccc(OC5(C)CC5)cc43)ccn2)CCO1.C[C@H]1CN(c2cc(C3=NCc4ccc(OC5(C)CC5)cc43)ccn2)CCO1.FC1(F)CN(c2cc(C3=NCc4ccc(OC5CC5)cc43)ccn2)C1.c1cc(C2=NCc3ccc(OC4CC4)cc32)cc(N2CCC(C3CC3)CC2)n1.
What is the InChIKey of 5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine?
The InChIKey is KFWHGKCMFIQHOF-FFCQYTTBSA-N. The full InChI is InChI=1S/C24H27N3O.2C22H25N3O2.C21H23N3O2.C19H17F2N3O/c1-2-16(1)17-8-11-27(12-9-17)23-13-18(7-10-25-23)24-22-14-21(28-20-5-6-20)4-3-19(22)15-26-24;2*1-15-14-25(9-10-26-15)20-11-16(5-8-23-20)21-19-12-18(27-22(2)6-7-22)4-3-17(19)13-24-21;1-21(5-6-21)26-17-3-2-16-14-23-20(18(16)13-17)15-4-7-22-19(12-15)24-8-10-25-11-9-24;20-19(21)10-24(11-19)17-7-12(5-6-22-17)18-16-8-15(25-14-3-4-14)2-1-13(16)9-23-18/h3-4,7,10,13-14,16-17,20H,1-2,5-6,8-9,11-12,15H2;2*3-5,8,11-12,15H,6-7,9-10,13-14H2,1-2H3;2-4,7,12-13H,5-6,8-11,14H2,1H3;1-2,5-8,14H,3-4,9-11H2/t;2*15-;;/m.10../s1.
What are the key properties of 5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine?
5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine has a molecular weight of 1791.22 g/mol, XLogP of 18.41, 21 rotatable bonds, 0 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 5-cyclopropyloxy-3-[2-(4-cyclopropylpiperidin-1-yl)-4-pyridinyl]-1H-isoindole;5-cyclopropyloxy-3-[2-(3,3-difluoroazetidin-1-yl)-4-pyridinyl]-1H-isoindole;4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2S)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine;(2R)-2-methyl-4-[4-[6-(1-methylcyclopropyl)oxy-3H-isoindol-1-yl]-2-pyridinyl]morpholine is sourced from PubChem (CID 159122504), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).